Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

GSK plc (GSK) Form 6-K — Sep 9, 2026

$GSKForm 6-KFiled Sep 9, 2026, 10:31 AM ET0001654954-26-008202Original filing

GSK plc granted a conditional share award of 85,714 Ordinary Shares to Roanne Parry, its Chief People Officer, under the GlaxoSmithKline 2017 Performance Share Plan on 8 September 2026, at a reference price of £18.3750 per share. Ms Parry joined GSK as Chief People Officer and an Executive Committee member on 1 May 2026. Her award is subject to the same performance measures as the 2026 awards granted to other Executive Committee members, with vesting dependent on performance over the three financial years from 1 January 2026 to 31 December 2028.

Key figures

Award Plan
GlaxoSmithKline 2017 Performance Share Plan
Instrument
Ordinary Shares of 31 1/4 pence each (ISIN GB00BN7SWP63)
Transaction Date
2026-09-08
Performance Period
2026-01-01 to 2028-12-31
Award Reference Price Gbp
18.375
Conditional Award Shares
85714

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.